CDK4/6 Tumor, Abemaciclib, Paclitaxel
NCT04594005
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Tumors
Interventions
DRUG:
abemaciclib+paclitaxel
Sponsor
Yonsei University